Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. Read more about Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.
Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review. Read more about Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
CYP3A variation, premenopausal estrone levels, and breast cancer risk. Read more about CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Bupropion for smoking cessation in African American light smokers: a randomized controlled trial. Read more about Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. Read more about Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Breast density influences tumor subtypes and tumor aggressiveness. Read more about Breast density influences tumor subtypes and tumor aggressiveness.
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. Read more about Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement. Read more about Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement.
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. Read more about Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. Read more about DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.
